Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bionic Yantra has developed wearable robotic exoskeletons and mobile robots for gait rehabilitation and early mobilization. Their flagship product, REARS, enables paralyzed or otherwise immobilized patients to stand and walk in a safe, fall-proof environment, with AI-driven personalized therapy. Early clinical validation has been reported, and the company is pursuing further clinical trials and regulatory approvals for international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bionic Yantra.